40 results
PRER14A
BXRXQ
Baudax Bio, Inc.
25 Aug 23
Preliminary revised proxy
4:01pm
raw materials, which may not be available to us on acceptable terms or at all.
Risks Relating to Our Intellectual Property
We own or license … materials, which may not be available to us on acceptable terms or at all.
Our Treg-based product candidates require many specialty raw materials, some
DEFA14A
EX-99.2
BXRXQ
Baudax Bio, Inc.
9 Aug 23
Additional proxy soliciting materials
5:28pm
profitability.
Cell-based therapies rely on the availability of specialty raw materials, which may not be available to us on acceptable terms or at all … on the availability of specialty raw materials, which may not be available to us on acceptable terms or at all.
Our Treg-based product candidates
8-K/A
EX-99.2
BXRXQ
Baudax Bio, Inc.
9 Aug 23
Other Events
5:27pm
profitability.
Cell-based therapies rely on the availability of specialty raw materials, which may not be available to us on acceptable terms or at all … on the availability of specialty raw materials, which may not be available to us on acceptable terms or at all.
Our Treg-based product candidates
424B3
85bwp dt5kv0ip3
28 Apr 23
Prospectus supplement
4:02pm
424B3
flnjuqcgg0mm4x1tuzi
5 Dec 22
Prospectus supplement
4:37pm
424B4
ax5ymbauoj8fqv7
31 Aug 22
Prospectus supplement with pricing info
4:08pm
S-1
sz2q342jyd pnwwsawv
3 Aug 22
IPO registration
5:17pm
424B5
nuaolxeshhl
19 May 22
Prospectus supplement for primary offering
6:07am